Algert Global LLC Sarepta Therapeutics, Inc. Transaction History

Algert Global LLC

$3.72 Billion
Q3 2024

A detailed history of Algert Global LLC transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Algert Global LLC holds 69,206 shares of SRPT stock, worth $7.99 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares

69,206

Previous 62,552 10.64%

Holding current value

$7.99 Million

Previous $9.88 Million 12.55%

% of portfolio

0.23%

Previous 0.33%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$124.33 - $156.75 $827,291 - $1.04 Million	6,654 Added 10.64%	69,206 $8.64 Million
Q2 2024 Aug 14, 2024	BUY	$113.33 - $163.85 $90,097 - $130,260	795 Added 1.29%	62,552 $9.88 Million
Q1 2024 May 14, 2024	BUY	$93.7 - $141.53 $1.43 Million - $2.16 Million	15,238 Added 32.76%	61,757 $8 Million
Q4 2023 Feb 14, 2024	BUY	$67.31 - $124.76 $224,613 - $416,324	3,337 Added 7.73%	46,519 $4.49 Million
Q3 2023 Nov 13, 2023	BUY	$102.5 - $123.59 $1.81 Million - $2.18 Million	17,670 Added 69.26%	43,182 $5.24 Million
Q2 2023 Aug 14, 2023	BUY	$106.4 - $157.19 $476,672 - $704,211	4,480 Added 21.3%	25,512 $2.92 Million
Q1 2023 May 12, 2023	SELL	$117.53 - $155.99 $3.67 Million - $4.87 Million	-31,212 Reduced 59.74%	21,032 $2.9 Million
Q4 2022 Feb 13, 2023	SELL	$100.86 - $132.13 $849,846 - $1.11 Million	-8,426 Reduced 13.89%	52,244 $6.77 Million
Q3 2022 Nov 15, 2022	BUY	$75.71 - $119.24 $1.32 Million - $2.08 Million	17,479 Added 40.47%	60,670 $6.71 Million
Q2 2022 Aug 15, 2022	SELL	$62.69 - $88.44 $238,974 - $337,133	-3,812 Reduced 8.11%	43,191 $3.24 Million
Q1 2022 May 16, 2022	BUY	$63.15 - $90.42 $2.09 Million - $2.99 Million	33,066 Added 237.25%	47,003 $3.67 Million
Q3 2021 Nov 15, 2021	BUY	$65.97 - $92.48 $919,423 - $1.29 Million	13,937 New	13,937 $1.29 Million
Q3 2020 Nov 16, 2020	SELL	$127.12 - $172.34 $780,262 - $1.06 Million	-6,138 Closed	0 $0
Q2 2020 Aug 12, 2020	BUY	$93.0 - $171.7 $570,834 - $1.05 Million	6,138 New	6,138 $984,000

Others Institutions Holding SRPT

# of Institutions

528

Shares Held

84.2M

Call Options Held

2.06M

Put Options Held

1.52M

View Full List

About Sarepta Therapeutics, Inc.

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10.1B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

More about SRPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Algert Global LLC, based on Form 13F filings with the SEC.

News

Stay updated on Algert Global LLC with notifications on news.

Account

Algert Global LLC Sarepta Therapeutics, Inc. Transaction History